Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
-
Orange Coast Women's Medical Group, Laguna Hills, California, United States, 92653
WR-PRI, LLC (Los Alamitos), Los Alamitos, California, United States, 90720
WR-PRI, LLC (Newport Beach), Newport Beach, California, United States, 92660
WR-Women's Health Care Research, LLC, San Diego, California, United States, 92111
WR-Multi-Specialty Research Associates, Lake City, Florida, United States, 32055
WR-Mount Vernon Clinical Research, LLC, Sandy Springs, Georgia, United States, 30328
WR-Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States, 89106
WR-Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States, 28303
WR-Charleston Clinical Trials, LLC, Charleston, South Carolina, United States, 29414
Southern Urogynecology, West Columbia, South Carolina, United States, 29169
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
FEMALE
No
Stratpharma AG,
2026-12